APO Research
Talk to an analyst

APO RESEARCH · REPORT

Basiliximab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Basiliximab Injection Market Analysis and Forecast 2026-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchBasiliximab Injection Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Basiliximab Injection Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Basiliximab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Basiliximab Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Basiliximab Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Basiliximab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Basiliximab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Basiliximab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Basiliximab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Basiliximab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Basiliximab Injection include Novartis AG and Ryvis Pharma etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Basiliximab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Basiliximab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Basiliximab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Basiliximab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Basiliximab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Basiliximab Injection sales, projected growth trends, production technology, application and end-user industry.

Basiliximab Injection Segment by Company

Novartis AG

Ryvis Pharma

Basiliximab Injection Segment by Type

20 mL

10 mL

Basiliximab Injection Segment by Application

Adult Use

Pediatric Use

Basiliximab Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Basiliximab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Basiliximab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Basiliximab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Basiliximab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Basiliximab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Basiliximab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Basiliximab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 20 mL Major Manufacturers Table 3. 10 mL Major Manufacturers Table 4. Global Basiliximab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Use Major Manufacturers Table 6. Pediatric Use Major Manufacturers Table 7. Basiliximab Injection Industry Trends Table 8. Basiliximab Injection Industry Drivers Table 9. Basiliximab Injection Industry Opportunities and Challenges Table 10. Basiliximab Injection Industry Restraints Table 11. Global Basiliximab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Basiliximab Injection Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Basiliximab Injection Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Basiliximab Injection Revenue Market Share by Region (2021-2026) Table 15. Global Basiliximab Injection Revenue Market Share by Region (2027-2032) Table 16. Global Basiliximab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K L) Table 17. Global Basiliximab Injection Sales by Region (2021-2026) & (K L) Table 18. Global Basiliximab Injection Sales by Region (2027-2032) & (K L) Table 19. Global Basiliximab Injection Sales Market Share by Region (2021-2026) Table 20. Global Basiliximab Injection Sales Market Share by Region (2027-2032) Table 21. Global Basiliximab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Basiliximab Injection Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Basiliximab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Basiliximab Injection Sales Market Share by Manufacturers (2021-2026) Table 25. Global Basiliximab Injection Sales Price (US$/L) of Manufacturers (2021-2026) Table 26. Global Basiliximab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Basiliximab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Basiliximab Injection Manufacturers, Product Type & Application Table 29. Global Basiliximab Injection Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Basiliximab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Basiliximab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Basiliximab Injection Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Basiliximab Injection Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Basiliximab Injection Revenue Market Share by Type (2021-2026) Table 36. Global Basiliximab Injection Revenue Market Share by Type (2027-2032) Table 37. Global Basiliximab Injection Sales by Type 2021 VS 2025 VS 2032 (K L) Table 38. Global Basiliximab Injection Sales by Type (2021-2026) & (K L) Table 39. Global Basiliximab Injection Sales by Type (2027-2032) & (K L) Table 40. Global Basiliximab Injection Sales Market Share by Type (2021-2026) Table 41. Global Basiliximab Injection Sales Market Share by Type (2027-2032) Table 42. Global Basiliximab Injection Price by Type (2021-2026) & (US$/L) Table 43. Global Basiliximab Injection Price by Type (2027-2032) & (US$/L) Table 44. Global Basiliximab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Basiliximab Injection Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Basiliximab Injection Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Basiliximab Injection Revenue Market Share by Application (2021-2026) Table 48. Global Basiliximab Injection Revenue Market Share by Application (2027-2032) Table 49. Global Basiliximab Injection Sales by Application 2021 VS 2025 VS 2032 (K L) Table 50. Global Basiliximab Injection Sales by Application (2021-2026) & (K L) Table 51. Global Basiliximab Injection Sales by Application (2027-2032) & (K L) Table 52. Global Basiliximab Injection Sales Market Share by Application (2021-2026) Table 53. Global Basiliximab Injection Sales Market Share by Application (2027-2032) Table 54. Global Basiliximab Injection Price by Application (2021-2026) & (US$/L) Table 55. Global Basiliximab Injection Price by Application (2027-2032) & (US$/L) Table 56. Novartis AG Company Information Table 57. Novartis AG Business Overview Table 58. Novartis AG Basiliximab Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 59. Novartis AG Basiliximab Injection Product Portfolio Table 60. Novartis AG Recent Development Table 61. Ryvis Pharma Company Information Table 62. Ryvis Pharma Business Overview Table 63. Ryvis Pharma Basiliximab Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 64. Ryvis Pharma Basiliximab Injection Product Portfolio Table 65. Ryvis Pharma Recent Development Table 66. North America Basiliximab Injection Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Basiliximab Injection Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Basiliximab Injection Sales by Type (2021-2026) & (K L) Table 69. North America Basiliximab Injection Sales by Type (2027-2032) & (K L) Table 70. North America Basiliximab Injection Sales Price by Type (2021-2026) & (US$/L) Table 71. North America Basiliximab Injection Sales Price by Type (2027-2032) & (US$/L) Table 72. North America Basiliximab Injection Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Basiliximab Injection Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Basiliximab Injection Sales by Application (2021-2026) & (K L) Table 75. North America Basiliximab Injection Sales by Application (2027-2032) & (K L) Table 76. North America Basiliximab Injection Sales Price by Application (2021-2026) & (US$/L) Table 77. North America Basiliximab Injection Sales Price by Application (2027-2032) & (US$/L) Table 78. North America Basiliximab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. North America Basiliximab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 80. North America Basiliximab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 81. North America Basiliximab Injection Sales by Country (2021 VS 2025 VS 2032) & (K L) Table 82. North America Basiliximab Injection Sales by Country (2021-2026) & (K L) Table 83. North America Basiliximab Injection Sales by Country (2027-2032) & (K L) Table 84. North America Basiliximab Injection Sales Price by Country (2021-2026) & (US$/L) Table 85. North America Basiliximab Injection Sales Price by Country (2027-2032) & (US$/L) Table 86. United States Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 87. Canada Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 88. Europe Basiliximab Injection Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Basiliximab Injection Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Basiliximab Injection Sales by Type (2021-2026) & (K L) Table 91. Europe Basiliximab Injection Sales by Type (2027-2032) & (K L) Table 92. Europe Basiliximab Injection Sales Price by Type (2021-2026) & (US$/L) Table 93. Europe Basiliximab Injection Sales Price by Type (2027-2032) & (US$/L) Table 94. Europe Basiliximab Injection Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Basiliximab Injection Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Basiliximab Injection Sales by Application (2021-2026) & (K L) Table 97. Europe Basiliximab Injection Sales by Application (2027-2032) & (K L) Table 98. Europe Basiliximab Injection Sales Price by Application (2021-2026) & (US$/L) Table 99. Europe Basiliximab Injection Sales Price by Application (2027-2032) & (US$/L) Table 100. Europe Basiliximab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Basiliximab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. Europe Basiliximab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. Europe Basiliximab Injection Sales by Country (2021 VS 2025 VS 2032) & (K L) Table 104. Europe Basiliximab Injection Sales by Country (2021-2026) & (K L) Table 105. Europe Basiliximab Injection Sales by Country (2027-2032) & (K L) Table 106. Europe Basiliximab Injection Sales Price by Country (2021-2026) & (US$/L) Table 107. Europe Basiliximab Injection Sales Price by Country (2027-2032) & (US$/L) Table 108. Germany Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 109. France Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 110. U.K. Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 111. Italy Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 113. China Basiliximab Injection Revenue by Type (2021-2026) & (US$ Million) Table 114. China Basiliximab Injection Revenue by Type (2027-2032) & (US$ Million) Table 115. China Basiliximab Injection Sales by Type (2021-2026) & (K L) Table 116. China Basiliximab Injection Sales by Type (2027-2032) & (K L) Table 117. China Basiliximab Injection Sales Price by Type (2021-2026) & (US$/L) Table 118. China Basiliximab Injection Sales Price by Type (2027-2032) & (US$/L) Table 119. China Basiliximab Injection Revenue by Application (2021-2026) & (US$ Million) Table 120. China Basiliximab Injection Revenue by Application (2027-2032) & (US$ Million) Table 121. China Basiliximab Injection Sales by Application (2021-2026) & (K L) Table 122. China Basiliximab Injection Sales by Application (2027-2032) & (K L) Table 123. China Basiliximab Injection Sales Price by Application (2021-2026) & (US$/L) Table 124. China Basiliximab Injection Sales Price by Application (2027-2032) & (US$/L) Table 125. Asia Basiliximab Injection Revenue by Type (2021-2026) & (US$ Million) Table 126. Asia Basiliximab Injection Revenue by Type (2027-2032) & (US$ Million) Table 127. Asia Basiliximab Injection Sales by Type (2021-2026) & (K L) Table 128. Asia Basiliximab Injection Sales by Type (2027-2032) & (K L) Table 129. Asia Basiliximab Injection Sales Price by Type (2021-2026) & (US$/L) Table 130. Asia Basiliximab Injection Sales Price by Type (2027-2032) & (US$/L) Table 131. Asia Basiliximab Injection Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Basiliximab Injection Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Basiliximab Injection Sales by Application (2021-2026) & (K L) Table 134. Asia Basiliximab Injection Sales by Application (2027-2032) & (K L) Table 135. Asia Basiliximab Injection Sales Price by Application (2021-2026) & (US$/L) Table 136. Asia Basiliximab Injection Sales Price by Application (2027-2032) & (US$/L) Table 137. Asia Basiliximab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Basiliximab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Asia Basiliximab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Asia Basiliximab Injection Sales by Country (2021 VS 2025 VS 2032) & (K L) Table 141. Asia Basiliximab Injection Sales by Country (2021-2026) & (K L) Table 142. Asia Basiliximab Injection Sales by Country (2027-2032) & (K L) Table 143. Asia Basiliximab Injection Sales Price by Country (2021-2026) & (US$/L) Table 144. Asia Basiliximab Injection Sales Price by Country (2027-2032) & (US$/L) Table 145. Japan Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 146. South Korea Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 147. India Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 148. Australia Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 149. China Taiwan Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 150. Southeast Asia Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 151. SAMEA Basiliximab Injection Revenue by Type (2021-2026) & (US$ Million) Table 152. SAMEA Basiliximab Injection Revenue by Type (2027-2032) & (US$ Million) Table 153. SAMEA Basiliximab Injection Sales by Type (2021-2026) & (K L) Table 154. SAMEA Basiliximab Injection Sales by Type (2027-2032) & (K L) Table 155. SAMEA Basiliximab Injection Sales Price by Type (2021-2026) & (US$/L) Table 156. SAMEA Basiliximab Injection Sales Price by Type (2027-2032) & (US$/L) Table 157. SAMEA Basiliximab Injection Revenue by Application (2021-2026) & (US$ Million) Table 158. SAMEA Basiliximab Injection Revenue by Application (2027-2032) & (US$ Million) Table 159. SAMEA Basiliximab Injection Sales by Application (2021-2026) & (K L) Table 160. SAMEA Basiliximab Injection Sales by Application (2027-2032) & (K L) Table 161. SAMEA Basiliximab Injection Sales Price by Application (2021-2026) & (US$/L) Table 162. SAMEA Basiliximab Injection Sales Price by Application (2027-2032) & (US$/L) Table 163. SAMEA Basiliximab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. SAMEA Basiliximab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. SAMEA Basiliximab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. SAMEA Basiliximab Injection Sales by Country (2021 VS 2025 VS 2032) & (K L) Table 167. SAMEA Basiliximab Injection Sales by Country (2021-2026) & (K L) Table 168. SAMEA Basiliximab Injection Sales by Country (2027-2032) & (K L) Table 169. SAMEA Basiliximab Injection Sales Price by Country (2021-2026) & (US$/L) Table 170. SAMEA Basiliximab Injection Sales Price by Country (2027-2032) & (US$/L) Table 171. Brazil Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 172. Argentina Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 173. Chile Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 174. Colombia Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 175. Peru Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 176. Saudi Arabia Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 177. Israel Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 178. UAE Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 179. Turkey Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 180. Iran Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 181. Egypt Basiliximab Injection Revenue (2021-2032) & (US$ Million) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Basiliximab Injection Distributors List Table 185. Basiliximab Injection Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Basiliximab Injection Image Figure 2. Global Basiliximab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Basiliximab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 20 mL Image Figure 5. 10 mL Image Figure 6. Global Basiliximab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Basiliximab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Use Image Figure 9. Pediatric Use Image Figure 10. Global Basiliximab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Basiliximab Injection Revenue (2021-2032) & (US$ Million) Figure 12. Global Basiliximab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Basiliximab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Basiliximab Injection Revenue Market Share by Region (2021-2032) Figure 15. Global Basiliximab Injection Sales (2021-2032) & (K L) Figure 16. Global Basiliximab Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 17. Global Basiliximab Injection Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Basiliximab Injection Sales YoY (2021-2032) & (K L) Figure 19. Europe Basiliximab Injection Sales YoY (2021-2032) & (K L) Figure 20. China Basiliximab Injection Sales YoY (2021-2032) & (K L) Figure 21. Asia (Excluding China) Basiliximab Injection Sales YoY (2021-2032) & (K L) Figure 22. South America, Middle East and Africa Basiliximab Injection Sales YoY (2021-2032) & (K L) Figure 23. Global Basiliximab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Basiliximab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Basiliximab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Basiliximab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Basiliximab Injection Revenue Market Share by Type (2021-2032) Figure 29. Global Basiliximab Injection Sales by Type (2021 VS 2025 VS 2032) & (K L) Figure 30. Global Basiliximab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Basiliximab Injection Sales Market Share by Type (2021-2032) Figure 32. Global Basiliximab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Basiliximab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Basiliximab Injection Revenue Market Share by Application (2021-2032) Figure 35. Global Basiliximab Injection Sales by Application (2021 VS 2025 VS 2032) & (K L) Figure 36. Global Basiliximab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Basiliximab Injection Sales Market Share by Application (2021-2032) Figure 38. North America Basiliximab Injection Revenue Share by Type (2021-2032) Figure 39. North America Basiliximab Injection Sales Share by Type (2021-2032) Figure 40. North America Basiliximab Injection Revenue Share by Application (2021-2032) Figure 41. North America Basiliximab Injection Sales Share by Application (2021-2032) Figure 42. North America Basiliximab Injection Revenue Share by Country (2021-2032) Figure 43. North America Basiliximab Injection Sales Share by Country (2021-2032) Figure 44. Europe Basiliximab Injection Revenue Share by Type (2021-2032) Figure 45. Europe Basiliximab Injection Sales Share by Type (2021-2032) Figure 46. Europe Basiliximab Injection Revenue Share by Application (2021-2032) Figure 47. Europe Basiliximab Injection Sales Share by Application (2021-2032) Figure 48. Europe Basiliximab Injection Revenue Share by Country (2021-2032) Figure 49. Europe Basiliximab Injection Sales Share by Country (2021-2032) Figure 50. China Basiliximab Injection Revenue Share by Type (2021-2032) Figure 51. China Basiliximab Injection Sales Share by Type (2021-2032) Figure 52. China Basiliximab Injection Revenue Share by Application (2021-2032) Figure 53. China Basiliximab Injection Sales Share by Application (2021-2032) Figure 54. Asia Basiliximab Injection Revenue Share by Type (2021-2032) Figure 55. Asia Basiliximab Injection Sales Share by Type (2021-2032) Figure 56. Asia Basiliximab Injection Revenue Share by Application (2021-2032) Figure 57. Asia Basiliximab Injection Sales Share by Application (2021-2032) Figure 58. Asia Basiliximab Injection Revenue Share by Country (2021-2032) Figure 59. Asia Basiliximab Injection Sales Share by Country (2021-2032) Figure 60. SAMEA Basiliximab Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA Basiliximab Injection Sales Share by Type (2021-2032) Figure 62. SAMEA Basiliximab Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA Basiliximab Injection Sales Share by Application (2021-2032) Figure 64. SAMEA Basiliximab Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA Basiliximab Injection Sales Share by Country (2021-2032) Figure 66. Basiliximab Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Basiliximab Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 20 mL
  • 10 mL
Applications
  • Adult Use
  • Pediatric Use
Companies covered
  • Novartis AG
  • Ryvis Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Basiliximab Injection Market by Type
  3. 1.2.1 Global Basiliximab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 20 mL
  5. 1.2.3 10 mL
  6. 1.3 Basiliximab Injection Market by Application
  7. 1.3.1 Global Basiliximab Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult Use
  9. 1.3.3 Pediatric Use
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Basiliximab Injection Market Dynamics
  1. 2.1 Basiliximab Injection Industry Trends
  2. 2.2 Basiliximab Injection Industry Drivers
  3. 2.3 Basiliximab Injection Industry Opportunities and Challenges
  4. 2.4 Basiliximab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Basiliximab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Basiliximab Injection Revenue by Region
  3. 3.2.1 Global Basiliximab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Basiliximab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Basiliximab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Basiliximab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Basiliximab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Basiliximab Injection Sales by Region
  9. 3.4.1 Global Basiliximab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Basiliximab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Basiliximab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Basiliximab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Basiliximab Injection Revenue by Manufacturers
  2. 4.1.1 Global Basiliximab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Basiliximab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Basiliximab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Basiliximab Injection Sales by Manufacturers
  6. 4.2.1 Global Basiliximab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Basiliximab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Basiliximab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Basiliximab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Basiliximab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Basiliximab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Basiliximab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Basiliximab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Basiliximab Injection Market CR5 and HHI
  16. 4.8.2 2025 Basiliximab Injection Tier 1, Tier 2, and Tier 3
5 Basiliximab Injection Market by Type
  1. 5.1 Global Basiliximab Injection Revenue by Type
  2. 5.1.1 Global Basiliximab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Basiliximab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Basiliximab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Basiliximab Injection Sales by Type
  6. 5.2.1 Global Basiliximab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Basiliximab Injection Sales by Type (2021-2032) & (K L)
  8. 5.2.3 Global Basiliximab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Basiliximab Injection Price by Type
6 Basiliximab Injection Market by Application
  1. 6.1 Global Basiliximab Injection Revenue by Application
  2. 6.1.1 Global Basiliximab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Basiliximab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Basiliximab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Basiliximab Injection Sales by Application
  6. 6.2.1 Global Basiliximab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Basiliximab Injection Sales by Application (2021-2032) & (K L)
  8. 6.2.3 Global Basiliximab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Basiliximab Injection Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Basiliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Basiliximab Injection Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Ryvis Pharma
  8. 7.2.1 Ryvis Pharma Company Information
  9. 7.2.2 Ryvis Pharma Business Overview
  10. 7.2.3 Ryvis Pharma Basiliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ryvis Pharma Basiliximab Injection Product Portfolio
  12. 7.2.5 Ryvis Pharma Recent Developments
8 North America
  1. 8.1 North America Basiliximab Injection Market Size by Type
  2. 8.1.1 North America Basiliximab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Basiliximab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Basiliximab Injection Price by Type (2021-2032)
  5. 8.2 North America Basiliximab Injection Market Size by Application
  6. 8.2.1 North America Basiliximab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Basiliximab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Basiliximab Injection Price by Application (2021-2032)
  9. 8.3 North America Basiliximab Injection Market Size by Country
  10. 8.3.1 North America Basiliximab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Basiliximab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Basiliximab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Basiliximab Injection Market Size by Type
  2. 9.1.1 Europe Basiliximab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Basiliximab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Basiliximab Injection Price by Type (2021-2032)
  5. 9.2 Europe Basiliximab Injection Market Size by Application
  6. 9.2.1 Europe Basiliximab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Basiliximab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Basiliximab Injection Price by Application (2021-2032)
  9. 9.3 Europe Basiliximab Injection Market Size by Country
  10. 9.3.1 Europe Basiliximab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Basiliximab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Basiliximab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Basiliximab Injection Market Size by Type
  2. 10.1.1 China Basiliximab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Basiliximab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Basiliximab Injection Price by Type (2021-2032)
  5. 10.2 China Basiliximab Injection Market Size by Application
  6. 10.2.1 China Basiliximab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Basiliximab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Basiliximab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Basiliximab Injection Market Size by Type
  2. 11.1.1 Asia Basiliximab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Basiliximab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Basiliximab Injection Price by Type (2021-2032)
  5. 11.2 Asia Basiliximab Injection Market Size by Application
  6. 11.2.1 Asia Basiliximab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Basiliximab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Basiliximab Injection Price by Application (2021-2032)
  9. 11.3 Asia Basiliximab Injection Market Size by Country
  10. 11.3.1 Asia Basiliximab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Basiliximab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Basiliximab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Basiliximab Injection Market Size by Type
  2. 12.1.1 SAMEA Basiliximab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Basiliximab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Basiliximab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Basiliximab Injection Market Size by Application
  6. 12.2.1 SAMEA Basiliximab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Basiliximab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Basiliximab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Basiliximab Injection Market Size by Country
  10. 12.3.1 SAMEA Basiliximab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Basiliximab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Basiliximab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Basiliximab Injection Value Chain Analysis
  2. 13.1.1 Basiliximab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Basiliximab Injection Production Mode & Process
  6. 13.2 Basiliximab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Basiliximab Injection Distributors
  9. 13.2.3 Basiliximab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst